March 10, 2023
Gregory Scherrer, PharmD, PhD, associate professor of cell biology and physiology and member of the UNC Neuroscience Center, received a Director’s Award for Excellence in Research, and Sarah Linnstaedt, PhD, associate professor of anesthesiology, earned an honorable mention for the Director’s Trailblazer award.
January 19, 2023
UNC Tobacco Prevention and Evaluation Program faculty Justin Byron, PhD, Chineme Enyioha, MD, MPH, and Adam Goldstein, MD, MPH, have published a lead commentary in the journal Nicotine & Tobacco Research outlining the communication research needed to accompany landmark regulation banning menthol in tobacco products.
November 9, 2022
Sarah Kowitt, PhD, MPH, assistant professor in the UNC Department of Family Medicine, was recently awarded a five-year, $762,196 grant by the National Cancer Institute (NCI) and the Food and Drug Administration (FDA). The Mentored Research Scientist Career Development Award (K01 grant) focuses on tobacco regulatory research in youth, specifically on how to communicate the harms of multiple tobacco products that youth may be using—referred to as multiple tobacco product (MTP) use—instead of just one product at a time.
November 9, 2022
Chineme Enyioha, MD, MPH, assistant professor in the UNC Department of Family Medicine, was recently awarded a K23 Career Development Award for a study entitled, “Development of a prototype for a mobile health intervention for smoking cessation with features culturally adapted for African American smokers.” Enyioha will focus her work on creating a mobile cessation system specifically targeted at African American smokers.
September 28, 2022
A research team from UNC-Chapel Hill, UC San Francisco, Yale, Duke, and Stanford developed a new compound that hits the same brain cell target as psychedelic drugs, triggering long-lasting anti-depressant action without psychedelic effects in mice.
July 19, 2022
UNC School of Medicine researchers led by Hyejung Won, PhD, used a new kind of computational tool to parse the complicated genetics that put some people at higher risk of becoming addicted to alcohol, cigarettes, and likely other substances of abuse.
April 11, 2022
Sarah Kowitt, PhD, MPH, Adam Goldstein, MD, MPH, and Samuel Cykert, MD, recently published a study that found a cardiovascular disease risk reduction intervention improved rates of tobacco screening and cessation support in small primary care practices in North Carolina.
March 2, 2022
The University of North Carolina at Chapel Hill's Department of Family Medicine is pleased to announce that Kimberly Shoenbill, MD, PhD, has been selected as the new Director of the UNC Tobacco Treatment and Weight Management Programs.
December 29, 2021
Kim Shoenbill, MD, PhD, at UNC Family Medicine and colleagues published the study "An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth" in Nicotine & Tobacco Research. The study provides the first analysis of inpatient tobacco use treatment during the transition to telehealth during the COVID-19 pandemic. It finds that telehealth services for inpatient populations resulted in a larger scope of patients reached and expanded participation in cessation counseling.
October 6, 2021
Leah Ranney, PhD, Director for Tobacco Prevention and Evaluation Program (TPEP) and team received a three-year NIH award in the amount of $1.2 million for the research study Strengthening Cigar Warnings to Prevent Adolescent Use.
December 1, 2020
Andrea Knittel, MD, PhD, FACOG, has been appointed as a Women’s Reproductive Health Research (WRHR) Scholar. Her work will focus on the health of women involved with the criminal justice system.
November 26, 2019
The Department of Pediatrics is proud to share a two part-webinar series on Neonatal Abstinence Syndrome, with content by Carl Seashore, MD, Professor of Pediatrics at UNC. This series provides those who serve infants with, or at-risk for, Neonatal Abstinence Syndrome (NAS) and their families the information they need to provide compassionate and effective support and intervention.